Enzo Biochem, Inc. (NYSE:ENZ – Get Free Report) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 605,300 shares, a growth of 8.0% from the June 15th total of 560,500 shares. Approximately 1.7% of the company’s shares are sold short. Based on an average daily trading volume, of 132,100 shares, the short-interest ratio is presently 4.6 days.
Enzo Biochem Stock Performance
Shares of ENZ traded down $0.04 on Thursday, hitting $1.13. 102,107 shares of the stock traded hands, compared to its average volume of 111,675. The stock’s 50 day moving average is $1.11 and its two-hundred day moving average is $1.21. Enzo Biochem has a 1 year low of $0.99 and a 1 year high of $1.71.
Enzo Biochem (NYSE:ENZ – Get Free Report) last announced its quarterly earnings data on Thursday, June 13th. The medical research company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $8.02 million for the quarter. Enzo Biochem had a net margin of 134.17% and a negative return on equity of 21.50%.
Hedge Funds Weigh In On Enzo Biochem
About Enzo Biochem
Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.
Read More
- Five stocks we like better than Enzo Biochem
- Why Invest in High-Yield Dividend Stocks?
- This Cybersecurity Stock Gains Analysts’ Favor for Strong Growth
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Parabolic Rise of This Stock Shows No Signs of Slowing
- Top Biotech Stocks: Exploring Innovation Opportunities
- Risk Tolerance vs. Risk Appetite: Key Differences
Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.